Abbott is an emerging leader in molecular diagnostics – one of the most promising new areas of medicine. Through leading-edge science and technologies, we’re helping physicians diagnose disease faster, select appropriate therapies and monitor disease progression by analysing DNA, RNA, and proteins at the molecular level.

With one of the broadest arrays of molecular diagnostic technologies, we continue to advance the belief that molecular diagnostics holds the promise of personalised healthcare and longer, healthier lives.

We are committed to bringing high quality, innovative molecular products to the physician, the laboratory and the patient.

Collaboration Across Many Disciplines
Abbott brings together scientists, physicians, and business professionals dedicated to advancing molecular diagnostics with breakthrough science and innovative technologies. Our research and development team includes engineers, virologists, biologists, geneticists, and oncologists.

They work alongside experts in nucleic acid chemistries, image analysis algorithms, FISH (fluorescence in situ hybridisation) probe development, amplification algorithms, and other specialised disciplines.

The full range of our expertise spans applied research to precision manufacturing and reliable, efficient performance in the field. Yet everything we do has the same objective: to discover, develop, and deliver innovative molecular diagnostic products that help people live longer, healthier lives. We see the chance to make a difference.

Science That Serves
Our commitment to this mission can be seen in our portfolio of products, focused on four critical areas: oncology, infectious diseases, pre- and post-natal testing, and organ transplantation. Today, our products help physicians guide treatment decisions for breast and bladder cancers.

We help physicians monitor and treat people with HIV, hepatitis and other infectious diseases. We help to identify the best potential donors for bone marrow transplants. We help to detect inherited genetic disorders, including mutations in the gene that causes cystic fibrosis. Thanks to our team of world-class scientists and engineers, even more innovation is on the way.

State-of-the-Art Facilities and Systems
Our ability to develop advanced medical technologies is equalled by our skill at bringing them to market. Our state-of-the-art R&D and manufacturing operations are dedicated expressly for the production of molecular diagnostic instruments and reagents.

A quality system specifically developed for Abbott Molecular is designed to meet the highest manufacturing standards in use today. Well-engineered, reliable, automated instrument systems help our customers speed the processing of samples and complete more tests with fewer people and less equipment. A dedicated sales force focuses exclusively on meeting the needs of molecular laboratories, physicians, and other customers throughout the world.

For more information about Abbott Molecular, please visit our website at
http://international.abbottmolecular.com/ or via:

Phone: 01628 784041
Fax: 01628 644414